| Code | 5537D | ||||||||||
| MA number | 63/0203/20-S | ||||||||||
| Product Form: | sol ijf 5x10 ml (liek.inj.skl.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Fresenius Kabi s.r.o., Czechia | ||||||||||
| Therapeutic Class: | 63 - MYORELAXANTIA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | glass vial | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 28.09.2020 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| PIL: |
PIL_Rocuronium Fresenius Kabi 10mg_ml_04_2024.pdf
|
| SPC: |
SPC_Rocuronium Fresenius Kabi 10mg_ml_04_2024.pdf
|
| Safety feature | Yes |
| Data update: | 27.10.2023 |
